President
Zhittya Genesis Medicine Inc.
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, Multiple sclerosis, and enhance stroke recovery.
Over 75 human diseases are known to result from lack of blood flow to a tissue or an organ. Learn ho...
New regenerative biopharmaceutical products are now under clinical development to stimulate the body...
Angiogenesis, or the re-growth of new blood vessels in damaged tissues, is an important regenerative...
The presentation will introduce our hypotheses that most neurodegenerative diseases are caused by "v...